Belgium Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Report Summary

GlobalData’s new report, “Belgium Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery” provides key market data on the Belgium Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for  Diabetes Care Devices  market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Belgium Diabetes Care Devicesmarket.        
• Key players covered include F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Sanofi, Medtronic, Inc., Novo Nordisk A/S, Becton, Dickinson and Company  and others.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Belgium Diabetes Care Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6

2 Introduction 8
2.1 What is This Report About? 8

3 Diabetes Care Devices In Belgium 9
3.1 Diabetes Care Devices, Market Segmentation 9
3.2 Diabetes Care Devices, Belgium, Overall Revenue ($m), USD Actual, 2003-2017 10
3.3 Diabetes Care Devices Market, Belgium, Revenue Mix ($m), 2010 11
3.4 Diabetes Care Devices Market, Belgium, Category Contribution (%), 2010 12
3.5 Diabetes Care Devices, Belgium, Category Volume (Units), 2003-2017 18
3.6 Diabetes Care Devices, Belgium, Company share (2009-2010) 21

4 Glucose Monitoring In Belgium 23
4.1 Glucose Monitoring, Market Segmentation 23
4.2 Glucose Monitoring Market, Belgium, Revenue Mix ($m), 2010 24
4.3 Glucose Monitoring Market, Belgium, Segment Contribution (%), 2010 25
4.4 Glucose Monitoring Overall Revenue (2003-2017) 26
4.4.1 Blood Glucose Meters Revenue (2003-2017) 30
4.5 Glucose Monitoring Overall Volume (2003-2017) 34
4.5.1 Blood Glucose Meters Volume (2003-2017) 37
4.6 Glucose Monitoring Average Price (2003-2017) 39
4.7 Glucose Monitoring Distribution Share (2009-2010) 40
4.8 Glucose Monitoring, Belgium, Company share (2009-2010) 41

5 Insulin Delivery In Belgium 43
5.1 Insulin Delivery, Market Segmentation 43
5.2 Insulin Delivery Market, Belgium, Revenue Mix ($m), 2010 44
5.3 Insulin Delivery Market, Belgium, Segment Contribution (%), 2010 45
5.4 Insulin Delivery Overall Revenue (2003-2017) 46
5.4.1 Insulin Pens Revenue (2003-2017) 50
5.4.2 Insulin Pumps Revenue (2003-2017) 54
5.5 Insulin Delivery Overall Volume (2003-2017) 56
5.5.1 Insulin Pens Volume (2003-2017) 60
5.5.2 Insulin Pumps Volume (2003-2017) 63
5.6 Insulin Delivery Average Price (2003-2017) 65
5.7 Insulin Delivery Distribution Share (2009-2010) 66
5.8 Insulin Delivery, Belgium, Company share (2009-2010) 67

6 Overview of Key Companies in Belgium Diabetes Care Devices Market 69
6.1 F. Hoffmann-La Roche Ltd. 69
6.1.1 Company Overview 69
6.1.2 Share in the Belgium Diabetes Care Devices Market 69
6.2 Eli Lilly and Company 70
6.2.1 Company Overview 70
6.2.2 Share in the Belgium Diabetes Care Devices Market 70
6.3 Sanofi 71
6.3.1 Company Overview 71
6.3.2 Share in the Belgium Diabetes Care Devices Market 71
6.4 Medtronic, Inc. 72
6.4.1 Company Overview 72
6.4.2 Share in the Belgium Diabetes Care Devices Market 72
6.5 Novo Nordisk A/S 73
6.5.1 Company Overview 73
6.5.2 Share in the Belgium Diabetes Care Devices Market 73
6.6 Becton, Dickinson and Company 74
6.6.1 Company Overview 74
6.6.2 Share in the Belgium Diabetes Care Devices Market 74
6.7 LifeScan, Inc. 75
6.7.1 Company Overview 75
6.8 Abbott Laboratories 75
6.8.1 Company Overview 75
6.9 Bayer HealthCare AG 75
6.9.1 Company Overview 75
6.10 Animas Corporation 76
6.10.1 Company Overview 76
6.11 Ypsomed Holding AG 76
6.11.1 Company Overview 76
6.12 NIPRO CORPORATION 76
6.12.1 Company Overview 76
6.13 ARKRAY, Inc. 77
6.13.1 Company Overview 77
6.14 Terumo Corporation 77
6.14.1 Company Overview 77

7 Diabetes Care Devices Market Pipeline Products 78

8 Appendix 82
8.1 Definitions of Markets Covered in the Report 83
8.1.1 Diabetes Care Devices 83
8.2 Research Methodology 86
8.3 Secondary Research 86
8.4 Primary Research 87
8.5 Models 87
8.6 Forecasts 88
8.7 Expert Panels 88
8.8 GlobalData Consulting 88
8.9 Currency Conversion 89
8.10 Contact Us 89
8.11 Disclaimer 89

List of Tables

Table 1:Diabetes Care Devices, Belgium, Overall Revenue ($m), USD Actual, 2003-2017 10
Table 2:Diabetes Care Devices Market, Belgium, Category Contribution (%), 2010 12
Table 3:Diabetes Care Devices, Belgium, Cross-Segment Analysis, 2003-2017 13
Table 4:Diabetes Care Devices, Belgium, Overall Revenue ($m), USD Actual, Historic, 2003-2010 15
Table 5:Diabetes Care Devices, Belgium, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 17
Table 6:Diabetes Care Devices, Belgium, Category Volume (Units), 2003-2017 18
Table 7:Diabetes Care Devices, Belgium, Category Volume (Units), Historic, 2003-2010 19
Table 8:Diabetes Care Devices, Belgium, Category Volume (Units), Forecast, 2010-2017 20
Table 9:Diabetes Care Devices, Belgium, Company share by Revenue ($m), USD Actual, 2009-2010 22
Table 10:Glucose Monitoring Market, Belgium, Segment Contribution (%), 2010 25
Table 11:Glucose Monitoring, Belgium, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 27
Table 12:Glucose Monitoring, Belgium, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 29
Table 13:Blood Glucose Meters, Belgium, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 31
Table 14:Blood Glucose Meters, Belgium, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 33
Table 15:Glucose Monitoring, Belgium, Volume (Units) by Segment, Historic, 2003-2010 35
Table 16:Glucose Monitoring, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 36
Table 17:Blood Glucose Meters, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 37
Table 18:Blood Glucose Meters, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 38
Table 19:Glucose Monitoring, Belgium, Average Price ($), Historic, 2003-2010 39
Table 20:Glucose Monitoring, Belgium, Average Price ($), Forecast, 2010-2017 39
Table 21:Glucose Monitoring, Belgium, Distribution Share by Revenue ($m), USD Actual, 2009-2010 40
Table 22:Glucose Monitoring, Belgium, Company share by Revenue ($m), USD Actual 2009-2010 42
Table 23:Insulin Delivery Market, Belgium, Segment Contribution (%), 2010 45
Table 24:Insulin Delivery, Belgium, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 47
Table 25:Insulin Delivery, Belgium, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 49
Table 26:Insulin Pens, Belgium, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 51
Table 27:Insulin Pens, Belgium, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 53
Table 28:Insulin Pumps (Traditional Insulin Pumps), Belgium, Revenue ($m), USD Actual, Historic, 2003-2010 54
Table 29:Insulin Pumps (Traditional Insulin Pumps), Belgium, Revenue ($m), USD Actual, Forecast, 2010-2017 55
Table 30:Insulin Delivery, Belgium, Volume (Units) by Segment, Historic, 2003-2010 57
Table 31:Insulin Delivery, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 59
Table 32:Insulin Pens, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 61
Table 33:Insulin Pens, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 62
Table 34:Insulin Pumps (Traditional Insulin Pumps), Belgium, Volume (Units), Historic, 2003-2010 63
Table 35:Insulin Pumps (Traditional Insulin Pumps), Belgium, Volume (Units), Forecast, 2010-2017 64
Table 36:Insulin Delivery, Belgium, Average Price ($), Historic, 2003-2010 65
Table 37:Insulin Delivery, Belgium, Average Price ($), Forecast, 2010-2017 65
Table 38:Insulin Delivery, Belgium, Distribution Share by Revenue ($m), USD Actual, 2009-2010 66
Table 39:Insulin Delivery, Belgium, Company share by Revenue ($m), USD Actual 2009-2010 68
Table 40:Diabetes Care Devices Market Pipeline Products 78
Table 41: USD to Local Currency, Belgium, Average Actual Rate 2003-2010 89

List of Figures

Figure 1:Diabetes Care Devices, Market Segmentation 9
Figure 2:Diabetes Care Devices, Belgium, Overall Revenue ($m), USD Actual, 2003-2017 10
Figure 3:Diabetes Care Devices Market, Belgium, Revenue Mix ($m), 2010 11
Figure 4:Diabetes Care Devices Market, Belgium, Category Contribution (%), 2010 12
Figure 5:Diabetes Care Devices, Belgium, Cross-Segment Analysis, 2003-2017 13
Figure 6:Diabetes Care Devices, Belgium, Overall Revenue ($m), USD Actual, Historic, 2003-2010 14
Figure 7:Diabetes Care Devices, Belgium, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 16
Figure 8:Diabetes Care Devices, Belgium, Category Volume (Units), 2003-2017 18
Figure 9:Diabetes Care Devices, Belgium, Category Volume (Units), Historic, 2003-2010 19
Figure 10:Diabetes Care Devices, Belgium, Category Volume (Units), Forecast, 2010-2017 20
Figure 11:Diabetes Care Devices, Belgium, Company share (%), 2010 21
Figure 12:Glucose Monitoring, Market Segmentation 23
Figure 13:Glucose Monitoring Market, Belgium, Revenue Mix ($m), 2010 24
Figure 14:Glucose Monitoring Market, Belgium, Segment Contribution (%), 2010 25
Figure 15:Glucose Monitoring, Belgium, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 26
Figure 16:Glucose Monitoring, Belgium, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 28
Figure 17:Blood Glucose Meters, Belgium, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 30
Figure 18:Blood Glucose Meters, Belgium, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 32
Figure 19:Glucose Monitoring, Belgium, Volume (Units) by Segment, Historic, 2003-2010 34
Figure 20:Glucose Monitoring, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 36
Figure 21:Blood Glucose Meters, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 37
Figure 22:Blood Glucose Meters, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 38
Figure 23:Glucose Monitoring, Belgium, Company share (%), 2010 41
Figure 24:Insulin Delivery, Market Segmentation 43
Figure 25:Insulin Delivery Market, Belgium, Revenue Mix ($m), 2010 44
Figure 26:Insulin Delivery Market, Belgium, Segment Contribution (%), 2010 45
Figure 27:Insulin Delivery, Belgium, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 46
Figure 28:Insulin Delivery, Belgium, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 48
Figure 29:Insulin Pens, Belgium, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 50
Figure 30:Insulin Pens, Belgium, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 52
Figure 31:Insulin Pumps (Traditional Insulin Pumps), Belgium, Revenue ($m), USD Actual, Historic, 2003-2010 54
Figure 32:Insulin Pumps (Traditional Insulin Pumps), Belgium, Revenue ($m), USD Actual, Forecast, 2010-2017 55
Figure 33:Insulin Delivery, Belgium, Volume (Units) by Segment, Historic, 2003-2010 56
Figure 34:Insulin Delivery, Belgium, Volume (Units) by Segment, Forecast, 2010-2017 58
Figure 35:Insulin Pens, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010 60
Figure 36:Insulin Pens, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017 62
Figure 37:Insulin Pumps (Traditional Insulin Pumps), Belgium, Volume (Units), Historic, 2003-2010 63
Figure 38:Insulin Pumps (Traditional Insulin Pumps), Belgium, Volume (Units), Forecast, 2010-2017 64
Figure 39:Insulin Delivery, Belgium, Company share (%), 2010 67
Figure 40:F. Hoffmann-La Roche Ltd., Company Share (%),Belgium Diabetes Care Devices Market, 2010 69
Figure 41:Eli Lilly and Company, Company Share (%),Belgium Diabetes Care Devices Market, 2010 70
Figure 42:Sanofi, Company Share (%),Belgium Diabetes Care Devices Market, 2010 71
Figure 43:Medtronic, Inc., Company Share (%),Belgium Diabetes Care Devices Market, 2010 72
Figure 44:Novo Nordisk A/S., Company Share (%),Belgium Diabetes Care Devices Market, 2010 73
Figure 45:Becton, Dickinson and Company, Company Share (%),Belgium Diabetes Care Devices Market, 2010 74